đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
Sabin 2 will be withdrawn from routine use globally from April 2016 as per ...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02521974
Treatments Being Tested
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The purpose of this study is to assess the immunogenicity in terms of antib...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-18
Trial ID
NCT00678301
Treatments Being Tested
A Phase 4 study to evaluate the safety and immunogenicity of monovalent ora...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02582255
Treatments Being Tested
This purpose of the study is to assess the safety and immunogenicity of a G...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01098474
Treatments Being Tested
This study is being done to assess the possibility of the potential integra...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-30
Trial ID
NCT00436007
Treatments Being Tested
In this study, the safety and tolerability of inactivated polio vaccine (IP...
Status
Completed
Location
University of Antwerpen
Start Date
2020-01-22
Trial ID
NCT04232943
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Meitetsu Hospital ( Site 2805)
Start Date
2019-04-02
Trial ID
NCT03848065